Exhibitor Details

Back

STIVAPH HEALTHCARE PRIVATE LIMITED

PF 01, SANAND GIDC INDUSTRIAL ESTATE-II, SANAND, AHMEDABAD, GUJARAT
HTTP://WWW.STIVAPH.COM/

Product Categories

Formulations
ACECLOFENAC (100 MG) + PARACETAMOL (500 MG),ALBENDAZOLE (400 MG),ARTEMETHER (180 MG) + LUMEFANTRINE (1080 MG),AZITHROMYCIN (500 MG),Captopril-25mg,DICLOFENAC (50 MG),DOXYCYCLINE (100 MG),FLUCONAZOLE (100 MG),FUROSEMIDE (10 MG),IBUPROFEN (100 MG) + PARACETAMOL (125 MG),LEVOCETIRIZINE (5 MG),LOSARTAN (100 MG),METRONIDAZOLE (500 MG),MONTELUKAST (10 MG) + LEVOCETIRIZINE (5 MG),PARACETAMOL (500 MG) + DICLOFENAC (50 MG) + CAFFEINE (30 MG),SILDENAFIL (100 MG)

Company Profile

WE ARE PLEASED TO INTRODUCE STIVAPH, A FULLY INTEGRATED PHARMACEUTICAL COMPANY INVOLVED IN THE DEVELOPMENT, MANUFACTURING, AND GLOBAL MARKETING OF PHARMACEUTICAL PRODUCTS. OUR MANUFACTURING FACILITY IS CERTIFIED WITH WHO GMP / YEMEN / PPB KENYA / CAMBODIA, AND DIGIMED - PERU (INTERIM) WHICH PRODUCE: SOLID ORAL DOSAGE FORMS (TABLETS & CAPSULES) LIQUID ORAL DOSAGE FORMS (SYRUPS & SUSPENSIONS) ORAL POWDER DOSAGE FORMS (DRY SUSPENSION & SACHETS) TOPICAL DOSAGE FORMS (GEL, CREAM, OINTMENTS) WE ARE CURRENTLY IN THE PROCESS OF SCHEDULING AUDITS FOR GHANA, NIGERIA, PHILIPPINES, UGANDA, MALAWI, TANZANIA ETC. WE ARE SPREAD ACROSS ALL MAJOR REGIONS OF AFRICA, SEA, LATAM, MENA & CIS. WE ARE KEEN TO EXPLORE POTENTIAL MARKET OPPORTUNITIES AND COLLABORATE WITH YOUR ESTEEMED ORGANIZATION REGARDING CMO/LICENSING FOR EXPORT AS WELL DOMESTIC BUSINESS AS WELL.